<PAGE>   1
                                                                   EXHIBIT 10.13

                        RESTRICTED STOCK AWARD AGREEMENT

                           Grantee:  Joseph B. Crace

                           Number of Shares:  3,500,000

                           Date of Grant: February 11, 2000

         1.    Grant of Shares. MD2patient, Inc. (the "Corporation") hereby
grants to the Grantee named above (the "Grantee"), as inducement for
employment, and subject to the restrictions and the other terms and conditions
set forth in this agreement (this "Agreement"), the number of shares indicated
above of the Corporation's $.01 par value common stock (the "Shares").

         2.    Defined Terms. The following capitalized terms used herein and
not otherwise defined shall have the following meanings.

               "Change in Control" means and includes each of the following:

                    (1)  The acquisition by any individual, entity or group
               (within the meaning of Section 13(d)(3) or 14(d)(2) of the 1934
               Act) (a "Person") of beneficial ownership (within the meaning of
               Rule 13d-3 promulgated under the 1934 Act) of 25% or more of the
               combined voting power of the then outstanding voting securities
               of the Corporation entitled to vote generally in the election of
               directors (the "Outstanding Company Voting Securities");
               provided, however, that for purposes of this subsection (1), the
               following acquisitions shall not constitute a Change of Control:
               (i) any acquisition by a Person who is on the Effective Date the
               beneficial owner of 25% or more of the Outstanding Company
               Voting Securities, (ii) any acquisition directly from the
               Corporation, (iii) any acquisition by the Corporation, (iv) any
               acquisition by any employee benefit plan (or related trust)
               sponsored or maintained by the Corporation or any corporation
               controlled by the Corporation, or (v) any acquisition by any
               corporation pursuant to a transaction which complies with
               clauses (i), (ii) and (iii) of subsection (3) of this
               definition; or

                    (2)  Individuals who, as of the Effective Date, constitute
               the Board (the "Incumbent Board") cease for any reason to
               constitute at least a majority of the Board; provided, however,
               that any individual becoming a director subsequent to the
               Effective Date whose election, or nomination for election by the
               Corporation's shareholders, was approved by a vote of at least a
               majority of the directors then comprising the Incumbent Board
               shall be considered as though such individual were a member of


<PAGE>   2

               the Incumbent Board, but excluding, for this purpose, any such
               individual whose initial assumption of office occurs as a result
               of an actual or threatened election contest with respect to the
               election or removal of directors or other actual or threatened
               solicitation of proxies or consents by or on behalf of a Person
               other than the Board; or

                    (3)  Consummation of a reorganization, merger or
               consolidation or sale or other disposition of all or
               substantially all of the assets of the Corporation (a "Business
               Combination"), in each case, unless, following such Business
               Combination, (i) all or substantially all of the individuals and
               entities who were the beneficial owners of the Outstanding
               Company Voting Securities immediately prior to such Business
               Combination beneficially own, directly or indirectly, more than
               50% of the combined voting power of the then outstanding voting
               securities entitled to vote generally in the election of
               directors of the corporation resulting from such Business
               Combination (including, without limitation, a corporation which
               as a result of such transaction owns the Corporation or all or
               substantially all of the Corporation's assets either directly or
               through one or more subsidiaries) in substantially the same
               proportions as their ownership, immediately prior to such
               Business Combination of the Outstanding Company Voting
               Securities, and (ii) no Person (excluding any corporation
               resulting from such Business Combination or any employee benefit
               plan (or related trust) of the Corporation or such corporation
               resulting from such Business Combination) beneficially owns,
               directly or indirectly, 25% or more of the combined voting power
               of the then outstanding voting securities of such corporation
               except to the extent that such ownership existed prior to the
               Business Combination, and (iii) at least a majority of the
               members of the board of directors of the corporation resulting
               from such Business Combination were members of the Incumbent
               Board at the time of the execution of the initial agreement, or
               of the action of the Board, providing for such Business
               Combination.

               "Committee" means the Compensation Committee of the Board of
          Directors of the Corporation.

               "Corporation" means MD2patient, Inc., a Georgia corporation.

               "Disability" shall mean any illness or other physical or mental
          condition of a Grantee that renders the Grantee incapable of
          performing his customary and usual duties for the Corporation, or any
          medically determinable illness or other physical or mental condition
          resulting from a bodily injury, disease or mental disorder which, in
          the judgment of the


                                     - 2 -
<PAGE>   3

          Committee, is permanent and continuous in nature. The Committee may
          require such medical or other evidence as it deems necessary to judge
          the nature and permanency of the Grantee's condition.

               "Stock" means the $.01 par value common stock of the Corporation
          and such other securities of the Corporation as may be substituted
          for Stock pursuant to Section 9.

               "Subsidiary" means any corporation, limited liability company,
          partnership or other entity of which a majority of the outstanding
          voting stock or voting power is beneficially owned directly or
          indirectly by the Corporation.

         3.    Restrictions. The Shares are subject to each of the following
restrictions. "Restricted Shares" mean those Shares which are subject to the
restrictions imposed hereunder which restrictions have not then expired or
terminated. Restricted Shares may not be sold, transferred, exchanged,
assigned, pledged, hypothecated or otherwise encumbered. If the Grantee's
employment with the Corporation or any Subsidiary terminates for any reason
other than as set forth in any of paragraphs (b) and (c) of Section 4 hereof,
then the Grantee shall forfeit all of the Grantee's right, title and interest
in and to the Restricted Shares as of the date of employment termination.

         The restrictions imposed under this Section shall apply to all shares
of the Corporation's Stock or other securities issued with respect to
Restricted Shares hereunder in connection with any merger, reorganization,
consolidation, recapitalization, stock dividend or other change in corporate
structure affecting the common stock of the Corporation.

         4.    Expiration and Termination of Restrictions. The restrictions
imposed under Section 3 will expire or terminate on the earliest to occur of
the following:

                    (a)  As to the Restricted Shares awarded hereunder
         (adjusted proportionately in the event of any change in the total
         numbers of Restricted Shares), at the rate of 1/36 of the Restricted
         Shares on the first day of each calendar month beginning January 1,
         2000;

                    (b)  On the first day of the calendar month next
         following the termination of the Grantee's employment with the
         Corporation or any Subsidiary because of his or her death or
         Disability; or

                    (c)  On the effective date of the dissolution or
         liquidation of the Corporation.


                                     - 3 -
<PAGE>   4

         5.    Acceleration of Vesting. Upon the occurrence of a Change in
Control, all restrictions on outstanding Restricted Shares shall lapse;
provided, however that such acceleration will not occur if, in the opinion of
the Corporation's accountants, such acceleration would preclude the use of
"pooling of interest" accounting treatment for a Change in Control transaction
that (i) would otherwise qualify for such accounting treatment, and (ii) is
contingent upon qualifying for such accounting treatment.

         6.    Delivery of Shares. The Shares will be issued in the name of the
Grantee as Restricted Stock and will be held by the Corporation during the
Restricted Period. Stock certificates shall be delivered as soon as practicable
after vesting of the Shares, but may be postponed for such period as may be
required for the Corporation with reasonable diligence to comply if deemed
advisable by the Corporation, with registration requirements under the
Securities Act, listing requirements under the rules of any stock exchange, and
requirements under any other law or regulation applicable to the issuance or
transfer of the Shares. Each certificate for Restricted Shares issued to the
Grantee under this Agreement shall be registered in the name of the Grantee and
shall bear a legend in substantially the following form:

         This certificate and the shares of stock represented hereby are
subject to the terms and conditions (including forfeiture and restrictions
against transfer) contained in a Restricted Stock Award Agreement dated January
1, 2000 between the registered owner of the shares represented hereby and
MD2patient, Inc. Release from such terms and conditions shall be made only in
accordance with the provisions of such Agreement, copies of which are on file
in the office of MD2patient, Inc.

         7.    Voting and Dividend Rights. The Grantee, as beneficial owner of
the Shares, shall have full voting and dividend rights with respect to the
Shares during the Restricted Period.

         8.    Restrictions on Transfer and Pledge. The Restricted Shares may
not be pledged, encumbered, or hypothecated to or in favor of any party other
than the Corporation or a Parent or Subsidiary, or be subject to any lien,
obligation, or liability of the Grantee to any other party other than the
Corporation or a Parent or Subsidiary. The Restricted Shares are not assignable
or transferable by the Grantee other than by will or the laws of descent and
distribution.

         9.    Changes in Capital Structure. In the event a stock dividend is
declared upon the Stock, the shares of Stock then subject to this Agreement
shall be increased proportionately. In the event the Stock shall be changed
into or exchanged for a different number or class of shares of stock or
securities of the Corporation or of another corporation, whether through
reorganization, recapitalization, reclassification, stock split-up, combination
of shares, merger or consolidation, there shall be substituted for each such
share of Stock then subject


                                     - 4 -
<PAGE>   5

to this Agreement the number and class of shares into which each outstanding
share of Stock shall be so exchanged.

         10.   No Right of Continued Employment. Nothing in this Agreement
shall interfere with or limit in any way the right of the Corporation or any
Parent or Subsidiary to terminate the Grantee's employment at any time, nor
confer upon the Grantee any right to continue in the employ of the Corporation
or any Parent or Subsidiary.

         11.   Payment of Taxes.

               (a)  The Grantee upon issuance of the Shares hereunder, shall
be authorized to make an election to be taxed upon such award under Section
83(b) of the Internal Revenue Code of 1986, as amended. To effect such
election, the Grantee may file an appropriate election with Internal Revenue
Service within thirty (30) days after award of the Shares and otherwise in
accordance with applicable Treasury Regulations.

               (b)  The Grantee will, no later than the date as of which any
amount related to the Shares first becomes includable in the Grantee's gross
income for federal income tax purposes, pay to the Corporation, or make other
arrangements satisfactory to the Committee regarding payment of, any federal,
state and local taxes of any kind required by law to be withheld with respect
to such amount. The obligations of the Corporation under this Agreement will be
conditional on such payment or arrangements, and the Corporation, and, where
applicable, its Subsidiaries will, to the extent permitted by law, have the
right to deduct any such taxes from any payment of any kind otherwise due to
the Grantee.

         12.   Amendment. The Committee may amend, modify or terminate this
Agreement without approval of the Grantee; provided, however, that such
amendment, modification or termination shall not, without the Grantee's
consent, reduce or diminish the value of this award determined as if it had
been fully vested on the date of such amendment or termination.

         13.   Successors. This Agreement shall be binding upon any successor
of the Corporation, in accordance with the terms of this Agreement.

         14.   Severability. If any one or more of the provisions contained in
this Agreement are invalid, illegal or unenforceable, the other provisions of
this Agreement will be construed and enforced as if the invalid, illegal or
unenforceable provision had never been included.

         15.   Notice. Notices and communications under this Agreement must be
in writing and either personally delivered or sent by registered or certified


                                     - 5 -
<PAGE>   6

United States mail, return receipt requested, postage prepaid. Notices to the
Corporation must be addressed to:

                  MD2patient, Inc.
                  Attn: President
                  501 Corporate Centre Drive, Suite 200
                  Franklin, Tennessee  37067

or any other address designated by the Corporation in a written notice to the
Grantee. Notices to the Grantee will be directed to the address of the Grantee
then currently on file with the Corporation, or at any other address given by
the Grantee in a written notice to the Corporation.

         IN WITNESS WHEREOF, MD2patient, Inc., acting by and through its duly
authorized officers, has caused this Agreement to be executed, and the Grantee
has executed this Agreement, all as of the day and year first above written.

                                MD2PATIENT, Inc.


                                By:      /s/ John E. Blount
                                   -------------------------------------------
                                Name:    John E. Blount
                                     -----------------------------------------
                                Title:   President
                                      ----------------------------------------

         I hereby accept the above Shares grant in accordance with and subject
to the terms and conditions set forth above.

         I agree that any shares of common stock received by me hereunder will
not be sold or otherwise disposed of by me except in a manner in compliance
with applicable securities laws.


                                GRANTEE:


                                             /s/ Joseph B. Crace
                                ----------------------------------------------
                                Joseph B. Crace



                                     - 6 -